Europe Biotechnology Market Size & Outlook, 2023-2030

The biotechnology market in Europe is expected to reach a projected revenue of US$ 1,144,370.4 million by 2030. A compound annual growth rate of 13.2% is expected of Europe biotechnology market from 2024 to 2030.

Revenue, 2023 (US$M)
$480,215.1
Forecast, 2030 (US$M)
$1,144,370.4
CAGR, 2024 - 2030
13.2%
Report Coverage
Europe

Europe biotechnology market highlights

  • The Europe biotechnology market generated a revenue of USD 480,215.1 million in 2023.
  • The market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
  • In terms of segment, health was the largest revenue generating application in 2023.
  • Bioinformatics is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 480,215.1 million
Market revenue in 2030USD 1,144,370.4 million
Growth rate13.2% (CAGR from 2023 to 2030)
Largest segmentHealth
Fastest growing segmentBioinformatics
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHealth, Food & Agriculture, Natural reseources & Environment, Industrial Processing, Bioinformatics, Others Applications
Key market players worldwideAstraZeneca PLC, Gilead Sciences Inc, Bristol-Myers Squibb Co, Sanofi SA, Biogen Inc, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk A/S ADR, Merck KGaA, Johnson & Johnson, Novartis AG ADR, Roche Holding AG, Lonza Group Ltd


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.9% of the global biotechnology market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 916,391.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biotechnology Market Scope

Biotechnology market segmentation & scope
Health
Food & Agriculture
Natural reseources & Environment
Industrial Processing
Bioinformatics
Others Applications
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others

Biotechnology Market Companies

Name Profile # Employees HQ Website

Europe biotechnology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology market will help companies and investors design strategic landscapes.


Health was the largest segment with a revenue share of 44.43% in 2023. Horizon Databook has segmented the Europe biotechnology market based on health, food & agriculture, natural reseources & environment, industrial processing, bioinformatics, others applications covering the revenue growth of each sub-segment from 2018 to 2030.


Europe has witnessed several developments in the field of stem cell research, cell therapy, personalized medicine, biopharmaceutical development, and proteomics. This is because of several initiatives undertaken by the government and nongovernment organizations for development of biotechnology sector in the region.


For instance, the Personalized Medicine 2020 and Beyond initiative included 14 countries and 27 organizations across Europe to enhance research in the area of personalized medicine. In addition, EMA supported the Innovative Medicine Initiative (IMI-2) project to enhance pharmaceutical research in Europe. The project is expected to be completed by 2024.


Similarly, the European Prospective Investigation into Cancer and Nutrition (EPIC) involves 10 countries across Europe to carry out biomarker and genetic investigations for 15 years. The ERA-Net on rare diseases project (E-Rare-3) involves 25 institutions located across 17 non-European, Europe associated, and European countries to study cell- and gene-drug therapy for rare disorders.

Reasons to subscribe to Europe biotechnology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe biotechnology market databook

  • Our clientele includes a mix of biotechnology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biotechnology market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe biotechnology market size, by country, 2018-2030 (US$M)

Europe Biotechnology Market Outlook Share, 2023 & 2030 (US$M)

Europe biotechnology market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more